High-concentration PRP. Precision-guided care.
Primary Joint Regenerative Treatment · $2,500
A comprehensive, provider-led procedure using platelet-rich plasma prepared from your own blood. Cyberdrip Health combines closed-system PRP processing, image guidance when indicated, individualized treatment and structured recovery support.
More than a standard PRP injection.
PRP quality depends on how the patient’s blood is collected, processed and concentrated. Cyberdrip Health uses a closed preparation system designed to produce a concentrated platelet product for provider-directed orthopedic and soft-tissue applications.
Every treatment begins with an evaluation of your symptoms, medical history, anatomy, previous treatment and available imaging. If PRP is appropriate, your provider develops a procedure and recovery plan around your specific condition and goals.
The preparation matters.
PRP stands for platelet-rich plasma. It is prepared by collecting a patient’s blood and separating the plasma and platelets from other blood components. Platelets contain signaling proteins and growth factors involved in the body’s natural healing response.
However, not every PRP preparation produces the same concentration, volume or cellular composition. The equipment, blood volume, processing protocol and clinical technique can materially affect the final product.
Cyberdrip Health uses the PURE closed-system PRP platform to prepare a high-concentration product according to an established clinical protocol.
Platelet concentration and composition vary by patient and collection. No preparation method guarantees a particular clinical result.
Designed around the joint, tissue and patient.
Following a medical evaluation, PRP may be considered as part of a conservative treatment strategy for eligible joint, tendon, ligament and soft-tissue concerns.
PRP is not appropriate for every condition. Some patients require diagnostic imaging, physical therapy, specialist evaluation or surgical care instead of, or in addition to, PRP.
One comprehensive regenerative-orthopedic experience.
Clinical evaluation
Review of your medical history, symptoms, previous treatment, medications, physical findings and relevant imaging.
High-concentration PRP preparation
Blood collection and closed-system processing performed according to the treatment protocol.
Precision treatment
Targeted injection into one primary eligible joint, tendon or soft-tissue area. Ultrasound guidance is used when clinically indicated.
Recovery support
Individualized post-procedure instructions, activity guidance and a complimentary Systemic Recovery IV when appropriate.
Clinical follow-up
Progress evaluation approximately four weeks after treatment, with additional recommendations based on your response.
The $2,500 price covers one Primary Joint Regenerative Treatment. Additional testing, imaging, supplies or specialist services are separate unless specifically included.
Premium treatment. Transparent pricing.
Regenerative Medicine Consultation
Approximately 45–60 minutes
- Medical and orthopedic evaluation
- Review of symptoms and previous treatment
- Review of available imaging
- Candidacy assessment
- Risks, benefits and alternatives
- Personalized treatment recommendation
The $250 consultation fee is applied toward a Primary Joint Regenerative Treatment completed within 30 days.
Primary Joint Regenerative Treatment
- Comprehensive orthopedic evaluation
- High-concentration PRP preparation
- One primary eligible treatment area
- Ultrasound-guided treatment when indicated
- Targeted PRP injection
- Post-treatment recovery protocol
- Complimentary Systemic Recovery IV when appropriate
- Four-week clinical follow-up
Secondary or Bilateral Joint
Same-session add-on
Treatment of a secondary eligible area or matching bilateral joint during the same appointment.
Subject to provider approval and sufficient treatment volume.
Regenerative Continuation Treatment
Established patients
An additional high-concentration PRP procedure for an established treatment area when recommended after clinical reassessment.
Available only to established Cyberdrip Health regenerative-medicine patients and at the provider’s discretion.
Platelet-Poor Plasma Treatment
+$250 / additional same-session area
Autologous platelet-poor plasma prepared from the patient’s blood and used when clinically appropriate.
- First eligible treatment area
- PPP preparation
- Targeted administration
- Post-procedure instructions
Regenerative-medicine services require an individualized medical evaluation and are not appropriate for every patient. PRP and PPP are prepared from the patient’s own blood using an FDA-cleared blood-processing system; this does not mean the PRP or PPP procedure is FDA-approved for a particular orthopedic condition. Treatment does not guarantee tissue regeneration, cartilage restoration, pain relief, avoidance of surgery or a specific clinical outcome. Temporary or serious adverse effects are possible and will be reviewed during informed consent. Imaging, laboratory testing, rehabilitation, medications, supplies and outside specialist services are separate unless specifically included. Individual results vary.
Evaluation, treatment and recovery, guided from start to finish.
Consultation
Meet with a Cyberdrip Health provider to review your symptoms, history, goals, previous treatment and available imaging.
Clinical planning
Your provider determines whether PRP is appropriate and whether additional imaging, testing or specialist evaluation is needed.
Procedure
Your blood is collected and processed using the closed PRP system. The final preparation is administered to the eligible treatment area.
Early recovery
You receive individualized instructions regarding activity, medications, exercise and symptoms that should prompt medical attention.
Reassessment
Your provider evaluates your progress and determines whether rehabilitation, continued observation or another procedure should be considered.
Improvement occurs on an individual timeline.
Temporary soreness, stiffness or swelling can occur around the treatment area.
Your provider may gradually adjust activity and rehabilitation recommendations.
Some patients report progressive changes in symptoms or function. Timing and degree of improvement vary.
Your provider evaluates progress and determines whether additional treatment or referral is appropriate.
This timeline is a general educational guide, not a prediction or guarantee. Some patients do not experience meaningful improvement.
Additional biologic options may be discussed during consultation.
Cyberdrip Health also evaluates select advanced biologic products, including exosome-based products, secretomes and extracellular-matrix products, where clinically appropriate and legally permitted.
These products are considered individually based on their source, composition, regulatory status, intended use and available supporting information. Their availability does not mean that treatment will be recommended.
Treatment involving an advanced biologic requires
Exosome-Based Products
Select extracellular-vesicle products may be reviewed during consultation when legally available. Product characteristics, sourcing and proposed use are evaluated individually.
Secretome Products
Select cell-signaling and secreted-factor products may be discussed following medical and regulatory review.
Extracellular-Matrix Products
Select structural-matrix products may be considered for provider-directed applications where legally permitted.
Advanced biologic products are available only following consultation. They cannot be purchased directly through the website.
Exosome-based, secretome, extracellular-matrix and related advanced biologic products are not FDA-approved to diagnose, treat, cure or prevent disease. FDA has not reviewed these products for safety, effectiveness, purity or potency for the uses discussed on this website. Mention of a product does not constitute a recommendation, guarantee availability or guarantee treatment. Treatment is considered only after an individualized medical evaluation, product-specific regulatory review and informed consent. Federal and state requirements may limit availability or use. Individual results vary.
Good to know.
Regenerative-medicine services require an individualized medical evaluation and are not appropriate for every patient. PRP and PPP are prepared from the patient’s own blood using an FDA-cleared blood-processing system; this does not mean the PRP or PPP procedure is FDA-approved for a particular orthopedic condition. Treatment does not guarantee tissue regeneration, cartilage restoration, pain relief, avoidance of surgery or a specific clinical outcome. Temporary or serious adverse effects are possible and will be reviewed during informed consent. Imaging, laboratory testing, rehabilitation, medications, supplies and outside specialist services are separate unless specifically included. Individual results vary.